Literature DB >> 25721496

Pityriazepin and other potent AhR ligands isolated from Malassezia furfur yeast.

Nikitia Mexia1, Georgios Gaitanis2, Aristea Velegraki3, Anatoly Soshilov4, Michael S Denison4, Prokopios Magiatis5.   

Abstract

Malassezia furfur yeast strains isolated from diseased human skin preferentially biosynthesize indole alkaloids which can be detected in the human skin and are highly potent activators of the aryl hydrocarbon receptor (AhR) and AhR-dependent gene expression. Chemical analysis of an EtOAc extract of a M. furfur strain obtained from diseased human skin and grown on l-tryptophan agar revealed several known AhR active tryptophan metabolites along with a previously unidentified compound, pityriazepin. While its structure resembled that of the known alkaloid pityriacitrin, the comprised pyridine ring had been transformed into an azepinone. The indoloazepinone scaffold of pityriazepin is extremely rare in nature and has only been reported once previously. Pityriazepin, like the other isolated compounds, was found to be a potent activator of the AhR-dependent reporter gene assay in recombinant cell lines derived from four different species, although significant species differences in relative potency were observed. The ability of pityriazepin to competitively bind to the AhR and directly stimulate AhR DNA binding classified it as a new naturally-occurring potent AhR agonist. M. furfur produces an expanded collection of extremely potent naturally occurring AhR agonists, which produce their biological effects in a species-specific manner.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aryl-hydrocarbon receptor; Indole metabolites; Malassezia furfur; Pityriacitrin; Pityriazepin

Mesh:

Substances:

Year:  2015        PMID: 25721496      PMCID: PMC4454357          DOI: 10.1016/j.abb.2015.02.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Malassezin--A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur.

Authors:  G Wille; P Mayser; W Thoma; T Monsees; A Baumgart; H J Schmitz; D Schrenk; K Polborn; W Steglich
Journal:  Bioorg Med Chem       Date:  2001-04       Impact factor: 3.641

2.  Inhibition of cytokine production by hymenialdisine derivatives.

Authors:  Vasudha Sharma; Theresa A Lansdell; Guangyi Jin; Jetze J Tepe
Journal:  J Med Chem       Date:  2004-07-01       Impact factor: 7.446

3.  Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells.

Authors:  C Vlachos; B M Schulte; P Magiatis; G J Adema; G Gaitanis
Journal:  Br J Dermatol       Date:  2012-07-19       Impact factor: 9.302

4.  The p38 MAPK inhibitor SB203580 induces cytochrome P450 1A1 gene expression in murine and human hepatoma cell lines through ligand-dependent aryl hydrocarbon receptor activation.

Authors:  Hesham M Korashy; Anwar Anwar-Mohamed; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Chem Res Toxicol       Date:  2011-07-27       Impact factor: 3.739

5.  Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.

Authors:  Alex W White; Nicholas Carpenter; Jerome R P Lottin; Richard A McClelland; Robert I Nicholson
Journal:  Eur J Med Chem       Date:  2012-08-24       Impact factor: 6.514

Review 6.  Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor.

Authors:  Michael S Denison; Anatoly A Soshilov; Guochun He; Danica E DeGroot; Bin Zhao
Journal:  Toxicol Sci       Date:  2011-09-09       Impact factor: 4.849

Review 7.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

8.  Third-generation Ah receptor-responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness.

Authors:  Guochun He; Tomoaki Tsutsumi; Bin Zhao; David S Baston; Jing Zhao; Sharon Heath-Pagliuso; Michael S Denison
Journal:  Toxicol Sci       Date:  2011-07-20       Impact factor: 4.849

9.  Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.

Authors:  Marie Knockaert; Marc Blondel; Stéphane Bach; Maryse Leost; Cem Elbi; Gordon L Hager; Scott R Nagy; Dalho Han; Michael Denison; Martine Ffrench; Xiaozhou P Ryan; Prokopios Magiatis; Panos Polychronopoulos; Paul Greengard; Leandros Skaltsounis; Laurent Meijer
Journal:  Oncogene       Date:  2004-05-27       Impact factor: 9.867

10.  AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis.

Authors:  George Gaitanis; Prokopios Magiatis; Konstantina Stathopoulou; Ioannis D Bassukas; Evangelos C Alexopoulos; Aristea Velegraki; Alexios-Leandros Skaltsounis
Journal:  J Invest Dermatol       Date:  2008-01-24       Impact factor: 8.551

View more
  16 in total

Review 1.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

2.  A Biomimetic, One-Step Transformation of Simple Indolic Compounds to Malassezia-Related Alkaloids with High AhR Potency and Efficacy.

Authors:  Nikitia Mexia; Stamatis Koutrakis; Guochun He; Alexios-Leandros Skaltsounis; Michael S Denison; Prokopios Magiatis
Journal:  Chem Res Toxicol       Date:  2019-11-07       Impact factor: 3.739

3.  Microbiota Metabolism Promotes Synthesis of the Human Ah Receptor Agonist 2,8-Dihydroxyquinoline.

Authors:  Troy D Hubbard; Qing Liu; Iain A Murray; Fangcong Dong; Charles Miller; Philip B Smith; Krishne Gowda; Jyh Ming Lin; Shantu Amin; Andrew D Patterson; Gary H Perdew
Journal:  J Proteome Res       Date:  2019-03-04       Impact factor: 4.466

4.  Development of Species-Specific Ah Receptor-Responsive Third Generation CALUX Cell Lines with Enhanced Responsiveness and Improved Detection Limits.

Authors:  Jennifer C Brennan; Guochun He; Tomoaki Tsutsumi; Jing Zhao; Edward Wirth; Michael H Fulton; Michael S Denison
Journal:  Environ Sci Technol       Date:  2015-09-24       Impact factor: 9.028

Review 5.  Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.

Authors:  Jing-Ru Liu; Hua Miao; De-Qiang Deng; Nosratola D Vaziri; Ping Li; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2020-09-23       Impact factor: 9.261

Review 6.  The Janus-Faced Role of Aryl Hydrocarbon Receptor Signaling in the Skin: Consequences for Prevention and Treatment of Skin Disorders.

Authors:  Thomas Haarmann-Stemmann; Charlotte Esser; Jean Krutmann
Journal:  J Invest Dermatol       Date:  2015-08-13       Impact factor: 8.551

7.  Diverse Secondary Metabolites from the Marine-Derived Fungus Dichotomomyces cejpii F31-1.

Authors:  Yan-Xiu Chen; Meng-Yang Xu; Hou-Jin Li; Kun-Jiao Zeng; Wen-Zhe Ma; Guo-Bao Tian; Jun Xu; De-Po Yang; Wen-Jian Lan
Journal:  Mar Drugs       Date:  2017-11-01       Impact factor: 5.118

Review 8.  Host Responses to Malassezia spp. in the Mammalian Skin.

Authors:  Florian Sparber; Salomé LeibundGut-Landmann
Journal:  Front Immunol       Date:  2017-11-22       Impact factor: 7.561

Review 9.  The mammalian mycobiome: A complex system in a dynamic relationship with the host.

Authors:  Ghee Chuan Lai; Tze Guan Tan; Norman Pavelka
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-09-25

Review 10.  Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs).

Authors:  Stephen Safe; Un-Ho Jin; Hyejin Park; Robert S Chapkin; Arul Jayaraman
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.